Clinical Trials Directory

Trials / Terminated

TerminatedNCT01089257

Cardiovascular Impairments and Obstructive Sleep Apnea Syndrome

Subclinical Cardiovascular Impairments in Patients With Obstructive Sleep Apnea Syndrome

Status
Terminated
Phase
Study type
Observational
Enrollment
133 (actual)
Sponsor
University Hospital, Grenoble · Academic / Other
Sex
All
Age
18 Years – 78 Years
Healthy volunteers
Accepted

Summary

Which are the anthropometric parameters and/or of severity of the syndrome of apnea of sleep (SAS) which make it possible to anticipate occurred of vascular anomalies, anatomical and/or functional precociously found among patients SAS? Secondary objectives: 1. Which are the anthropometric parameters and/or of severity of SAS allowing to anticipate occurred of early of the cardiac function and/or rhythmic anomalies found among patients SAS? 2. Do there exist biological markers who allow to anticipate the early vascular lesions or the anomalies beginners of the cardiac function? 3. Which are the cardiovascular effects of a treatment of SAS by Continuous Positive Pressure (PC) after 3 to 6 months of treatment? 4. Do the identified early cardiovascular attacks and/or the biological anomalies make it possible to predict occurred of cardiovascular events in this population of patients carrying SAS (followed longitudinal at 5 years)?

Conditions

Timeline

Start date
2007-11-01
Primary completion
2012-11-01
Completion
2021-06-01
First posted
2010-03-18
Last updated
2025-12-29

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01089257. Inclusion in this directory is not an endorsement.

Cardiovascular Impairments and Obstructive Sleep Apnea Syndrome (NCT01089257) · Clinical Trials Directory